Skip to content

Board of Directors

***

Thomas Eldered MSc

Thomas Eldered MSc

Non-Executive Chairman

In addition to being the Non Executive Chairman of Cobra Biologics, Thomas has held the position of CEO at Recipharm AB since 2008, a Swedish company with a turnover of approximately £500m, which employs more than 4,500 people across a number of sites in Europe. Prior to Recipharm Thomas was Vice President of Recip AB from 1995 to 2007 and Factory Manager at Pharmacia from 1990 to 1995.

He has a M.Sc. in Industrial and Management Engineering from the Linköping Institute of Technology.

Peter Coleman FCMA, MBA

Peter Coleman FCMA, MBA

Chief Executive

Prior to his appointment as CEO in May 2011, Peter was Finance Director at Cobra and Recipharm Ltd, Ashton. Peter was also Finance Director of Cobra Biomanufacturing Plc up to its acquisition by Recipharm in 2010, and he has been at the Keele facility for more than nine years.

Prior to Cobra he was employed in a number of senior financial and corporate development roles. Peter was awarded an MBA with distinction jointly from the Manchester Business School and the University of Wales.

Carl-Johan Spak PhD

Carl-Johan Spak PhD

Non-Executive Director

Carl Johan is a Non Executive Director for Cobra Biologics and is also currently employed by Recipharm AB as Executive Vice President Global Technologies. He has been with Recipharm AB since 2009.

Prior to his appointment at Recipharm he was Meda AB’s Director for the Nordic Region, from 2007 to 2008, CEO for Recip AB and Recip Läkemedel AB from 2005 to 2007, and part of the Executive Management Team for Recip AB from 1995 to 2005. Carl-Johan is a non-executive member of several boards within the biotech area.

Professor Carl Johan Sundberg MD, PhD

Professor Carl Johan Sundberg MD, PhD

Non-Executive Director

Carl Johan is a licensed physician and professor at the Department of Physiology & Pharmacology at Karolinska Institutet in Stockholm, Sweden. Carl Johan co-founded the Karolinska Investment Fund, a €60m biomedical VC fund where he worked from 1999 to 2009 as Investment Manager.

He also heads the Unit for Bio-entrepreneurship at Karolinska Institutet, is a member of the International Olympic Committee´s Medical Commission and an elected member of the Royal Swedish Academy of Engineering Sciences (IVA). Carl Johan has also served as a member or chairman of numerous academic and industry boards.

Elisabeth Lindner MSc, MBA

Elisabeth Lindner MSc, MBA

Non-Executive Director

Elisabeth lives in Stockholm, Sweden and is a member of the Royal Swedish Academy of Engineering Sciences. In addition to being a Cobra Biologics board member, she is Chairman and CEO of BioSource Europe AB and currently CEO for the Oxthera Group.

Elisabeth has significant senior management experience with Pharmacia Corporation, Octapharma AB and Diamyd Medical AB.

Jinyue Wang PhD

Jinyue Wang PhD

Non-Executive Director

Jinyue lives in Beijing, China where he is the founder and Managing Partner of 3N Partners, an investment partnership that is focused on life science, nutrition & food, and Cleantech VC investment, as well as providing advisory services for M&A activities in the pharmaceutical sector.

Prior to the current role, he founded and headed DSM Venturing in China. He has significant experience in the Chinese healthcare industry, working for Roche, DSM and the Chinese central government from 1996. During his career he has reviewed more than 800 deals, completed more than 50 due diligences and closed 16 deals.

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies